Mar 2024
Dec 2023
May 2023
Philadelphia, PA., May 4, 2023– NeuExcell Therapeutics (www.neuexcell.com), a gene therapy company focusing on neurodegenerative diseases, has announced a $15+ million Series Pre-A+ financing round.
Oct 2022
Sep 2022
NeuExcell Therapeutics has been invited to participate in the upcoming UBS Biotechnology Private Company Symposium, Wednesday September 21, 2022